PDK4 and Other metabolic disease: Since the incapacity of insulin to downregulate PDK4 has been demonstrated in obese and diabetic subjects (170), the consequent increase in the PDK4 levels associated with an inappropriate suppression of the PDHC activity may promote the development of metabolic diseases (171).